Diabetes duration or age at onset and mortality in insulin-dependent diabetics: a systematic review and meta-analysis.

Age at onset Diabetes duration IDDM Meta-analysis Mortality Risk Systematic review

Journal

Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958

Informations de publication

Date de publication:
01 Jul 2023
Historique:
received: 27 05 2023
accepted: 15 06 2023
medline: 2 7 2023
pubmed: 2 7 2023
entrez: 1 7 2023
Statut: epublish

Résumé

This meta-analysis was conducted given the contradictory findings from studies on the influence of diabetes duration or age at onset on mortality in patients with insulin-dependent diabetes mellitus (IDDM). Electronic databases (PubMed, Embase, Cochrane, Web of Knowledge, Scopus, and CINHAL) were comprehensively searched to identify relevant studies until October 31, 2022. All of the selected articles contained statistics on hazard ratios, relative risks (RRs), or odds ratios, or data for estimating the association between diabetes duration or age at onset and total mortality in IDDM patients. Regardless the heterogeneity assessed by the I This meta-analysis finally included 19 studies involving 122, 842 individuals. Both age at onset and diabetes duration were positively associated with an increased mortality rate in IDDM patients. Specifically, the pooled RRs for age at onset and diabetes duration were 1.89 (95%CI 1.43-2.50) and 1.89 (95%CI 1.16-3.09) respectively. Subgroup analyses revealed that only prepubertal onset was associated with a greater survival advantage than pubertal or postpubertal onset. The findings of this meta-analysis and systematic review suggest that a later age at onset or longer diabetes duration is associated with increased risk of total mortality in IDDM patients. However, this conclusion shall be interpreted with caution due to the possibility of residual confounding and be confirmed in the future by well-designed studies.

Sections du résumé

BACKGROUND BACKGROUND
This meta-analysis was conducted given the contradictory findings from studies on the influence of diabetes duration or age at onset on mortality in patients with insulin-dependent diabetes mellitus (IDDM).
METHODS METHODS
Electronic databases (PubMed, Embase, Cochrane, Web of Knowledge, Scopus, and CINHAL) were comprehensively searched to identify relevant studies until October 31, 2022. All of the selected articles contained statistics on hazard ratios, relative risks (RRs), or odds ratios, or data for estimating the association between diabetes duration or age at onset and total mortality in IDDM patients. Regardless the heterogeneity assessed by the I
RESULTS RESULTS
This meta-analysis finally included 19 studies involving 122, 842 individuals. Both age at onset and diabetes duration were positively associated with an increased mortality rate in IDDM patients. Specifically, the pooled RRs for age at onset and diabetes duration were 1.89 (95%CI 1.43-2.50) and 1.89 (95%CI 1.16-3.09) respectively. Subgroup analyses revealed that only prepubertal onset was associated with a greater survival advantage than pubertal or postpubertal onset.
CONCLUSIONS CONCLUSIONS
The findings of this meta-analysis and systematic review suggest that a later age at onset or longer diabetes duration is associated with increased risk of total mortality in IDDM patients. However, this conclusion shall be interpreted with caution due to the possibility of residual confounding and be confirmed in the future by well-designed studies.

Identifiants

pubmed: 37393334
doi: 10.1186/s13098-023-01113-x
pii: 10.1186/s13098-023-01113-x
pmc: PMC10314605
doi:

Types de publication

Journal Article

Langues

eng

Pagination

147

Informations de copyright

© 2023. The Author(s).

Références

Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Diabetologia. 2019 Jul;62(7):1167-1172
pubmed: 30969375
Diabetes. 1984 Mar;33(3):271-6
pubmed: 6698317
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Diabetes Res Clin Pract. 2007 Feb;75(2):214-9
pubmed: 16876284
Diabet Med. 2006 Jun;23(6):698-706
pubmed: 16759315
J Clin Endocrinol Metab. 1995 Mar;80(3):846-51
pubmed: 7883841
Diabetes Care. 2010 Sep;33(9):2043-8
pubmed: 20530748
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
Acta Diabetol. 2017 Jun;54(6):535-542
pubmed: 28251285
Diabetes. 1985 Sep;34(9):926-30
pubmed: 3896901
Pediatr Diabetes. 2022 Dec;23(8):1560-1566
pubmed: 36193929
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
Diabet Med. 2000 Oct;17(10):727-34
pubmed: 11110506
Diabetes. 1986 Jan;35(1):20-7
pubmed: 3940909
Circulation. 2007 Jan 23;115(3):387-97
pubmed: 17242296
Diabetes. 2016 May;65(5):1362-9
pubmed: 26858360
Lancet Diabetes Endocrinol. 2022 Oct;10(10):741-760
pubmed: 36113507
Diabetologia. 1994 Mar;37(3):247-51
pubmed: 8174837
N Engl J Med. 1983 Sep 1;309(9):527-30
pubmed: 6348545
Sci Rep. 2020 Sep 8;10(1):14790
pubmed: 32901098
Diabetes Care. 2003 Jul;26(7):2037-42
pubmed: 12832309
Diabetologia. 1991 Jul;34(7):515-20
pubmed: 1916057
Diabetologia. 1986 Nov;29(11):767-72
pubmed: 3493184
Lancet. 2018 Aug 11;392(10146):477-486
pubmed: 30129464
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Circulation. 2004 Apr 13;109(14):1750-5
pubmed: 15023875
Diabetes Care. 1998 Oct;21(10):1674-9
pubmed: 9773729
Diabetes Care. 2012 Mar;35(3):542-8
pubmed: 22238277
Lancet Diabetes Endocrinol. 2022 Oct;10(10):688-689
pubmed: 36113506
Diabetes Res Clin Pract. 2008 Apr;80(1):e6-9
pubmed: 18329123
World J Diabetes. 2020 Apr 15;11(4):95-99
pubmed: 32313608
Diabetes Care. 2018 Apr;41(4):748-754
pubmed: 29378776
Diabetes Res Clin Pract. 2022 Jan;183:109119
pubmed: 34879977
Diabetes Res Clin Pract. 2014 Mar;103(3):504-9
pubmed: 24439208
Circulation. 2014 Oct 21;130(17):1532-58
pubmed: 25170098
Diabetes Care. 1994 Jun;17(6):531-4
pubmed: 8082520
Cell Biochem Biophys. 2015 Sep;73(1):181-5
pubmed: 25711186
Am J Epidemiol. 1991 Jan;133(1):67-72
pubmed: 1983900
Diabetologia. 2015 Aug;58(8):1779-86
pubmed: 25972232
Diabetes Care. 1996 Jan;19(1):74-5
pubmed: 8720540
Eur Heart J. 2013 Aug;34(31):2436-43
pubmed: 23641007
N Engl J Med. 1986 Jul 24;315(4):215-9
pubmed: 3523245
Eur Heart J. 2017 Aug 21;38(32):2459-2472
pubmed: 28444290
Psychol Methods. 2001 Sep;6(3):203-17
pubmed: 11570228
Diabetes Care. 2010 Dec;33(12):2573-9
pubmed: 21115767
Diabet Med. 2018 Jun;35(6):729-736
pubmed: 29532512
Diabetes Care. 1997 Aug;20(8):1237-41
pubmed: 9250446
Eur J Clin Nutr. 2019 Jan;73(1):1-8
pubmed: 29765164
Lancet. 2009 Jun 13;373(9680):2027-33
pubmed: 19481249
BMJ. 2011 Sep 08;343:d5364
pubmed: 21903695
Diabetes. 2014 Nov;63(11):3835-45
pubmed: 24939426
Diabetologia. 2007 Dec;50(12):2439-42
pubmed: 17901942
Diabet Med. 2018 Jan;35(1):112-120
pubmed: 29111600

Auteurs

Xing-Mu Wang (XM)

Clinical Laboratory Center, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, Zhejiang, People's Republic of China.

Shu-Ping Zhong (SP)

Department of Hospital Management, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, Zhejiang, People's Republic of China.

Gang-Feng Li (GF)

Clinical Laboratory Center, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, Zhejiang, People's Republic of China.

Fu-Yuan Zhuge (FY)

Department of Endocrine and Metabolism, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Yuecheng District, No.568, Zhongxing North Road, Shaoxing, Zhejiang, People's Republic of China. ffyyzg120@126.com.

Classifications MeSH